Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 1486 AL 1500

Potential applications of using tissue-specific EVs in targeted therapy and vaccinology

Lehmann TP, Golik M, Olejnik J, Łukaszewska M, Markowska D, Drożdżyńska M, Kotecki A, Głowacki M, Jagodziński PP.

Biomed Pharmacother. 2023 Oct;166:115308. doi: 10.1016/j.biopha.2023.115308. Epub 2023 Sep 4.

Uncovering the neurophysiology of mood, motivation and behavioral symptoms in Parkinson's disease through intracranial recordings

Ricciardi L, Apps M, Little S.

NPJ Parkinsons Dis. 2023 Sep 21;9(1):136. doi: 10.1038/s41531-023-00567-0.

Therapeutic considerations of bioactive compounds in Alzheimer's disease and Parkinson's disease: Dissecting the molecular pathways

Phukan BC, Roy R, Gahatraj I, Bhattacharya P, Borah A.

Phytother Res. 2023 Dec;37(12):5657-5699. doi: 10.1002/ptr.8012. Epub 2023 Oct 12.

Overview on wearable sensors for the management of Parkinson's disease

Moreau C, Rouaud T, Grabli D, Benatru I, Remy P, Marques AR, Drapier S, Mariani LL, Roze E, Devos D, Dupont G, Bereau M, Fabbri M.

NPJ Parkinsons Dis. 2023 Nov 2;9(1):153. doi: 10.1038/s41531-023-00585-y.

Common and Trace Metals in Alzheimer's and Parkinson's Diseases

Doroszkiewicz J, Farhan JA, Mroczko J, Winkel I, Perkowski M, Mroczko B.

Int J Mol Sci. 2023 Oct 29;24(21):15721. doi: 10.3390/ijms242115721.

Pharmacological Properties of Shionone: Potential Anti-Inflammatory Phytochemical against Different Diseases

Jaiswal V, Lee HJ.

Molecules. 2023 Dec 28;29(1):189. doi: 10.3390/molecules29010189.

Reactive astrocytes associated with prion disease impair the blood brain barrier

Kushwaha R, Li Y, Makarava N, Pandit NP, Molesworth K, Birukov KG, Baskakov IV.

bioRxiv [Preprint]. 2023 Mar 24:2023.03.21.533684. doi: 10.1101/2023.03.21.533684.

Differential LRRK2 signalling and gene expression in WT-LRRK2 and G2019S-LRRK2 mouse microglia treated with zymosan and MLi2

Nazish I, Mamais A, Mallach A, Bettencourt C, Kaganovich A, Warner T, Hardy J, Lewis PA, Pocock J, Cookson MR, Bandopadhyay R.

bioRxiv [Preprint]. 2023 Sep 14:2023.09.14.557532. doi: 10.1101/2023.09.14.557532.

omicSynth: an Open Multi-omic Community Resource for Identifying Druggable Targets across Neurodegenerative Diseases

Alvarado CX, Makarious MB, Weller CA, Vitale D, Koretsky MJ, Bandres-Ciga S, Iwaki H, Levine K, Singleton A, Faghri F, Nalls MA, Leonard HL.

medRxiv [Preprint]. 2023 Jul 14:2023.04.06.23288266. doi: 10.1101/2023.04.06.23288266.

Microbiome-Based Therapies in Parkinson's Disease: Can Tuning the Microbiota Become a Viable Therapeutic Strategy?

Onaolapo AY, Ojo FO, Olofinnade AT, Falade J, Lawal IA, Onaolapo OJ.

CNS Neurol Disord Drug Targets. 2023;22(9):1355-1368. doi: 10.2174/1871527321666220903114559.

Effective Management of "OFF" Episodes in Parkinson's Disease: Emerging Treatment Strategies and Unmet Clinical Needs

Masood N, Jimenez-Shahed J.

Neuropsychiatr Dis Treat. 2023 Jan 25;19:247-266. doi: 10.2147/NDT.S273121. eCollection 2023.

GBA1 Gene Mutations in α-Synucleinopathies-Molecular Mechanisms Underlying Pathology and Their Clinical Significance

Granek Z, Barczuk J, Siwecka N, Rozpędek-Kamińska W, Kucharska E, Majsterek I.

Int J Mol Sci. 2023 Jan 20;24(3):2044. doi: 10.3390/ijms24032044.

Alpha Synuclein: Neurodegeneration and Inflammation

Forloni G.

Int J Mol Sci. 2023 Mar 21;24(6):5914. doi: 10.3390/ijms24065914.

Sex and Gender Differences in Neurodegenerative Diseases: Challenges for Therapeutic Opportunities

Bianco A, Antonacci Y, Liguori M.

Int J Mol Sci. 2023 Mar 28;24(7):6354. doi: 10.3390/ijms24076354.

Novel Therapeutic Opportunities for Neurodegenerative Diseases with Mesenchymal Stem Cells: The Focus on Modulating the Blood-Brain Barrier

Vargas-Rodríguez P, Cuenca-Martagón A, Castillo-González J, Serrano-Martínez I, Luque RM, Delgado M, González-Rey E.

Int J Mol Sci. 2023 Sep 14;24(18):14117. doi: 10.3390/ijms241814117.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias